Free tool
FAERS Monitor: Valtoco
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 211635 or its brand name (Valtoco, Diazepam). Reports on generic versions are filed under their own applications.
Reports
90,834
Serious
77,085
85% of reports
Hospitalization
31,371
Death reported
20,903
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxicity to various agents9,224
- drug abuse6,198
- drug ineffective5,161
- nausea4,223
- drug interaction3,890
- completed suicide3,880
- fatigue3,865
- somnolence3,697
- off label use3,647
- death3,415
- anxiety3,398
- headache3,292
- pain3,242
- overdose3,230
- vomiting3,135
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,140 |
| 2005 | 1,344 |
| 2006 | 1,170 |
| 2007 | 1,233 |
| 2008 | 1,797 |
| 2009 | 1,793 |
| 2010 | 2,345 |
| 2011 | 2,776 |
| 2012 | 3,252 |
| 2013 | 3,740 |
| 2014 | 3,766 |
| 2015 | 4,657 |
| 2016 | 5,306 |
| 2017 | 5,529 |
| 2018 | 6,524 |
| 2019 | 7,146 |
| 2020 | 6,752 |
| 2021 | 5,754 |
| 2022 | 5,062 |
| 2023 | 4,948 |
| 2024 | 5,314 |
| 2025 | 5,358 |
| 2026 | 4,117 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,963,325 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 6,198 | 18.5 | 18.1 | 95,596 |
| toxicity to various agentsSignal | 9,224 | 13.3 | 13.1 | 100,327 |
| completed suicideSignal | 3,880 | 11.3 | 10.9 | 34,708 |
| drug interactionSignal | 3,890 | 5.8 | 5.6 | 15,166 |
| somnolenceSignal | 3,697 | 4.3 | 4.2 | 9,319 |
| overdoseSignal | 3,230 | 3.5 | 3.4 | 5,752 |
| anxietySignal | 3,398 | 2.8 | 2.7 | 3,895 |
| vomiting | 3,135 | 1.5 | 1.5 | 617 |
| nausea | 4,223 | 1.2 | 1.2 | 198 |
| pain | 3,242 | 1.2 | 1.2 | 135 |
| headache | 3,292 | 1.2 | 1.2 | 130 |
| fatigue | 3,865 | 1.2 | 1.1 | 78 |
| off label use | 3,647 | 1.0 | 0.9 | 5 |
| death | 3,415 | 0.9 | 0.9 | 26 |
| drug ineffective | 5,161 | 0.9 | 0.9 | 53 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.